Could a Low-Dose Diuretic Polypill Improve Outcomes in Heart Failure With Preserved Ejection Fraction?
作者信息
Khan Sadiya S, Huffman Mark D, Shah Sanjiv J
机构信息
Division of Cardiology, Department of Medicine (S.S.K.,M.D.H., S.J.S.), Northwestern University Feinberg School of Medicine, Chicago, IL.
Department of Preventive Medicine (S.S.K., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL.
出版信息
Circ Heart Fail. 2021 Mar;14(3):e008090. doi: 10.1161/CIRCHEARTFAILURE.120.008090. Epub 2021 Mar 5.
Abstract
摘要
相似文献
1
Could a Low-Dose Diuretic Polypill Improve Outcomes in Heart Failure With Preserved Ejection Fraction?低剂量利尿复方制剂能否改善射血分数保留的心力衰竭患者的预后？
Circ Heart Fail. 2021 Mar;14(3):e008090. doi: 10.1161/CIRCHEARTFAILURE.120.008090. Epub 2021 Mar 5.
2
Improving Care for Heart Failure With Reduced Ejection Fraction-A Potential Polypill-Based Strategy.改善射血分数降低的心力衰竭的治疗——一种基于多效药丸的潜在策略。
JAMA. 2020 Dec 8;324(22):2259-2260. doi: 10.1001/jama.2020.21395.
3
[Diuretic therapy in acute heart failure].[急性心力衰竭的利尿治疗]
Med Clin (Barc). 2014 Mar;142 Suppl 1:36-41. doi: 10.1016/S0025-7753(14)70081-8.
4
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.在射血分数降低的心力衰竭患者中，较高剂量的襻利尿剂会限制血管紧张素转换酶抑制剂的剂量递增。
Clin Res Cardiol. 2020 Aug;109(8):1048-1059. doi: 10.1007/s00392-020-01598-w. Epub 2020 Jan 30.
5
Use of natriuretic-doses of spironolactone for treatment of loop diuretic resistant acute decompensated heart failure.使用利尿剂量的螺内酯治疗对袢利尿剂抵抗的急性失代偿性心力衰竭。
Int J Cardiol. 2014 Jan 1;170(3):e68-9. doi: 10.1016/j.ijcard.2013.11.023. Epub 2013 Nov 12.
6
Loop Diuretic Use and Outcomes in Chronic Stable Heart Failure With Preserved Ejection Fraction-Reply.射血分数保留的慢性稳定心力衰竭中袢利尿剂的使用及预后——回复
Mayo Clin Proc. 2021 Feb;96(2):503-506. doi: 10.1016/j.mayocp.2020.11.006.
7
Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.在急性失代偿性心力衰竭中辅助使用美托拉宗或高剂量袢利尿剂的策略相关结局：倾向评分分析。
J Am Heart Assoc. 2018 Sep 18;7(18):e009149. doi: 10.1161/JAHA.118.009149.
8
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial.在 2 型糖尿病合并慢性心力衰竭患者中 SGLT2 抑制剂联合袢利尿剂的肾脏和心血管影响：RECEDE-CHF 试验。
Circulation. 2020 Nov 3;142(18):1713-1724. doi: 10.1161/CIRCULATIONAHA.120.048739. Epub 2020 Aug 29.
9
Combination of loop diuretics with thiazide-type diuretics in heart failure.心力衰竭中袢利尿剂与噻嗪类利尿剂的联合应用。
J Am Coll Cardiol. 2010 Nov 2;56(19):1527-34. doi: 10.1016/j.jacc.2010.06.034.
10
Patients with acute heart failure treated with the CARRESS-HF diuretic protocol in association with canrenoate potassium: Tolerance of high doses of canrenoate potassium.CARRESS-HF 利尿方案联合坎利酸钾治疗急性心力衰竭患者：高剂量坎利酸钾的耐受性。
Arch Cardiovasc Dis. 2020 Nov;113(11):679-689. doi: 10.1016/j.acvd.2020.05.017. Epub 2020 Sep 15.
引用本文的文献
1
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review.高血压伴射血分数保留的急性和慢性心力衰竭的药物治疗：最新综述。
Am J Cardiovasc Drugs. 2024 May;24(3):343-369. doi: 10.1007/s40256-024-00641-9. Epub 2024 Apr 4.
2
Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials.射血分数保留的心力衰竭的药物治疗和合并症管理进展：来自临床试验的证据
Heart Fail Rev. 2024 Mar;29(2):305-320. doi: 10.1007/s10741-023-10338-x. Epub 2023 Aug 10.
3
Moving the Paradigm Forward for Prediction and Risk-Based Primary Prevention of Heart Failure in Special Populations.推动特殊人群心力衰竭预测及基于风险的一级预防模式的发展。
Curr Atheroscler Rep. 2022 May;24(5):343-356. doi: 10.1007/s11883-022-01009-7. Epub 2022 Mar 2.
4
Frontiers of cardiovascular polypills: From atherosclerosis and beyond.心血管复方药丸的前沿：从动脉粥样硬化到超越。
Trends Cardiovasc Med. 2023 Apr;33(3):182-189. doi: 10.1016/j.tcm.2021.12.013. Epub 2021 Dec 30.
本文引用的文献
1
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.非奈利酮对 2 型糖尿病患者慢性肾脏病结局的影响。
N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23.
2
Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.普立芦那格对射血分数保留的心力衰竭患者峰值摄氧量的影响：CAPACITY HFpEF 随机临床试验。
JAMA. 2020 Oct 20;324(15):1522-1531. doi: 10.1001/jama.2020.16641.
3
Polypharmacy in Older Adults Hospitalized for Heart Failure.老年心力衰竭住院患者的多种药物治疗。
Circ Heart Fail. 2020 Nov;13(11):e006977. doi: 10.1161/CIRCHEARTFAILURE.120.006977. Epub 2020 Oct 13.
4
Dapagliflozin in Patients with Chronic Kidney Disease.达格列净治疗慢性肾脏病患者。
N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24.
5
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.2020年2型糖尿病患者降低心血管风险新型疗法专家共识决策路径：美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2020 Sep 1;76(9):1117-1145. doi: 10.1016/j.jacc.2020.05.037. Epub 2020 Aug 5.
6
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials.估算射血分数降低的心力衰竭患者接受全面疾病修正药物治疗的终生获益：三项随机对照试验的比较分析。
Lancet. 2020 Jul 11;396(10244):121-128. doi: 10.1016/S0140-6736(20)30748-0. Epub 2020 May 21.
7
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.《心脏病与卒中统计-2020 更新：来自美国心脏协会的报告》。
Circulation. 2020 Mar 3;141(9):e139-e596. doi: 10.1161/CIR.0000000000000757. Epub 2020 Jan 29.
8
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.达格列净治疗射血分数降低的心力衰竭患者。
N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.
9
Disparities in Cardiovascular Mortality Related to Heart Failure in the United States.美国与心力衰竭相关的心血管疾病死亡率差异
J Am Coll Cardiol. 2019 May 14;73(18):2354-2355. doi: 10.1016/j.jacc.2019.02.042.
10
Clinical Pharmacology in Diuretic Use.利尿剂使用中的临床药理学
Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1248-1257. doi: 10.2215/CJN.09630818. Epub 2019 Apr 1.
Zotero 插件